Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels

被引:124
作者
Zhou, S
Zong, Y
Ney, PA
Nair, G
Stewart, CF
Sorrentino, BP
机构
[1] St Jude Childrens Res Hosp, Div Expt Hematol, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
关键词
D O I
10.1182/blood-2004-04-1566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ABCG2/BCRP is a member of the adenosine triphosphate-binding cassette (ABC) transporter family and is expressed in intestine, kidney, and liver, where it modulates the absorption. and excretion of xenobiotic compounds, ABCG2 is also expressed in hematopoietic stem cells and erythroid cells; however, little is known regarding its role in hematopoiesis. Abcg2 null mice have increased levels of protoporphyrin IX (PPIX) in erythroid cells, yet the mechanism for this remains uncertain. We have found that Abcg2 mRNA expression was up-regulated in differentiating erythroid cells, coinciding with increased expression of other erythroid-specific genes. This expression pattern was associated with significant amounts of ABCG2 protein on the membrane of mature peripheral blood erythrocytes. Erythroid cells engineered to express ABCG2 had significantly lower intracellular levels of PPIX, suggesting the modulation of PPIX level by ABCG2. This modulating activity was abrogated by treatment with a specific ABCG2 inhibitor, Ko143, implying that PPIX may be a direct substrate for the transporter. Taken together, our results demonstrate that ABCG2 plays a role in regulating PPIX levels during erythroid differentiation and suggest a potential role for ABCG2 as a genetic determinant in erythropoietic protoporphyria. (c) 2005 by The American Society of Hematology
引用
收藏
页码:2571 / 2576
页数:6
相关论文
共 30 条
[1]   Low levels of ABCG2 expression in adult AML blast samples [J].
Abbott, BL ;
Colapietro, AM ;
Barnes, Y ;
Marini, F ;
Andreeff, M ;
Sorrentino, BP .
BLOOD, 2002, 100 (13) :4594-4601
[2]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[3]  
Allen JD, 1999, CANCER RES, V59, P4237
[4]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[5]   ERYTHROPOIETIC PROTOPORPHYRIA - 10 YEARS EXPERIENCE [J].
DELEO, VA ;
POHFITZPATRICK, M ;
MATHEWSROTH, M ;
HARBER, LC .
AMERICAN JOURNAL OF MEDICINE, 1976, 60 (01) :8-22
[6]   Photodynamic therapy for cancer [J].
Dolmans, DEJGJ ;
Fukumura, D ;
Jain, RK .
NATURE REVIEWS CANCER, 2003, 3 (05) :380-387
[7]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[8]  
FERREIRA GC, 1988, J BIOL CHEM, V263, P3835
[9]   A comparative study of normal and reverse phase high pressure liquid chromatography for analysis of porphyrins accumulated after 5-aminolaevulinic acid treatment of colon adenocarcinoma cells [J].
Gederaas, OA ;
Berg, K ;
Romslo, I .
CANCER LETTERS, 2000, 150 (02) :205-213
[10]   Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species [J].
Goodell, MA ;
Rosenzweig, M ;
Kim, H ;
Marks, DF ;
DeMaria, M ;
Paradis, G ;
Grupp, SA ;
Sieff, CA ;
Mulligan, RC ;
Johnson, RP .
NATURE MEDICINE, 1997, 3 (12) :1337-1345